Latest in Cardiology from ACC.org

• Complications After Noncardiac Surgery Not Improved With Personalized Perioperative BP Management
  Neither individualized perioperative blood pressure (BP) management nor management stratified by risk of intraoperative hypotension improved outcomes in patients after noncardiac surgery, according to results of the IMPROVE-multi and PRETREAT trials, published recently in JAMA.
• JACC: Asia and JACC: Advances Now Eligible For Impact Factors
  The ACC is excited to announce that two of its JACC Journals – JACC: Asia and JACC: Advances – will receive an official Impact Factor, with the first rankings being issued in June 2026 as part of the Clarivate release.
• "Can We Clip It?": A Review of TEER in the Adult Congenital Heart Disease Population
  Atrioventricular valvular regurgitation (AVVR) is commonly seen in adults with congenital heart disease (ACHD), including those with congenitally corrected transposition of the great arteries (ccTGA), atrial switch correction for dextro-transposition of the great arteries (d-TGA), atrioventricular (AV) canal defect, and single-ventricle Fontan circulation.
• ACC CardiaCast: Innovation in Action: Ensuring Equity in AI-Enabled ECG
  In this episode, ACC Chief Innovation Officer Dr. Ami Bhatt explores the application of artificial intelligence (AI) in electrocardiogram (ECG) with Drs. Demilade Adedinsewo and Ambarish Pandey.
• New Science Presented at GW-ICC/AHS.25 Examines Effects of Intensive BP Lowering
  Four studies presented at the 36th Great Wall International Congress of Cardiology/Asian Heart Society Congress 2025 (GW-ICC/AHS.25) and simultaneously published in JACC examined the effects of intensive blood pressure (BP) lowering in certain populations, on the retinal microvasculature and more.